関節痛注射市場：注射タイプ別、関節タイプ別、流通チャネル別、地域別

世界の関節痛注射市場は、2024年には52億9,000万米ドルと推定され、2031年には94億6,000万米ドルに達すると予測され、2024年から2031年までのCAGRは8.7%です。

図.関節痛注射市場シェア（%）、地域別、2024年

関節痛用注射剤の世界市場は、過去数年間で着実な成長を遂げています。関節痛は、関節炎、怪我、加齢に伴う軟骨や骨の炎症や損傷につながる消耗など、さまざまな状態によって生じる。関節注射は、関節に直接薬剤を投与することにより、痛みを軽減し、可動性を回復するのに役立ちます。一般的な関節注射には、コルチコステロイド注射、ヒアルロン酸注射、多血小板血漿注射などがあります。関節障害を起こしやすい老年人口の増加と肥満の有病率の増加が、世界的に関節痛注射の需要を煽っています。さらに、革新的な治療法の登場と有利な償還政策が、この市場のプレーヤーに新たな機会を生み出しています。

市場力学：

世界の関節痛注射市場は、高齢者人口の増加、肥満率の上昇、関節炎の有病率の上昇によって牽引されています。推計によると、現在、世界人口の10％以上が何らかの関節炎を患っており、この症状は女性や高齢者に多く見られます。さらに、肥満は変形性膝関節症の主な危険因子であり、肥満率が大幅に急増すれば、関節痛注射の必要性がさらに高まると思われます。しかし、特に革新的な生物学的製剤は治療費が高いため、市場成長の妨げになる可能性があります。プラス面としては、先進的な生物学的製剤の投入が新たな機会を提供しています。市場開拓者はまた、アンメットニーズに対応し、顧客層を拡大することができる、長期持続型で費用対効果の高い治療法を開発するために、研究開発への投資を増やしています。

本調査の主な特徴

• 本レポートでは、世界の関節痛注射市場を詳細に分析し、2023年を基準年とした予測期間（2024年～2031年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
• また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の関節痛注射市場の主要企業をプロファイルしています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界の関節痛注射剤市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の関節痛注射剤市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の関節痛注射市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の関節痛注射市場、注射タイプ別、2019年-2031年

• コルチコステロイド注射
• ヒアルロン酸注射
• 多血小板血漿注射
• その他

第6章 世界の関節痛注射市場、関節タイプ別、2019年-2031年

• 膝と足首
• 股関節
• 手と手首
• その他
• 細胞不死化技術

第7章 世界の関節痛注射市場、流通チャネル別、2019年-2031年

• 病院薬局
• 小売薬局
• オンライン薬局

第8章 世界の関節痛注射市場、地域別、2019年-2031年

第9章 競合情勢

• 企業プロファイル
  • Pfizer, Inc.
  • Ferring Pharmaceuticals Inc.
  • PACIRA BIOSCIENCES
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Sanofi
  • Anika Therapeutics, Inc.
  • Bioventus
  • Dr. Reddy's Laboratories Ltd.
  • Zimmer Biomet
  • Ferring BV
  • SEIKAGAKU CORPORATION

第10章 アナリストの見解

• Wheel of Fortune
• アナリストの見解
• Coherent Opportunity Map

第11章 参考文献と調査手法

• 参考文献
• 調査手法

The global joint pain injections market is estimated to be valued at USD 5.29 Bn in 2024 and is expected to reach USD 9.46 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.

Figure. Joint Pain Injections Market Share (%), By Region, 2024

The global joint pain injections market has been witnessing steady growth in the past few years. Joint pain arises due to various conditions like arthritis, injuries, and age-related wear and tear that lead to inflammation and damage of cartilage and bones. Joint injections help in reducing pain and restoring mobility by delivering medications directly into the joint. Some common joint injections include corticosteroid injections, hyaluronic acid injections, and platelet-rich plasma injections. The rising geriatric population prone to joint disorders as well as the growing prevalence of obesity are fueling the demand for joint pain injections globally. Additionally, the advent of innovative therapies and favorable reimbursement policies are creating new opportunities for players in this market.

Market Dynamics:

The global joint pain injections market is driven by the growing geriatric population, increasing obesity rates, and rising prevalence of arthritis. According to estimates, over 10% of the world's population suffers from some form of arthritis currently and the condition is more common in women and elderly. Moreover, obesity is a major risk factor for knee osteoarthritis and as obesity rates surge significantly, it will further propel the need for joint pain injections. However, the market growth can be hindered by the high cost of therapies especially innovative biologic products. On the positive side, infusion of advanced biologic therapies offers new opportunities. Market players are also investing more in R&D to develop long-lasting and cost-effective therapies which can address the unmet needs and expand the customer pool.

Key Features of the Study:

• This report provides an in-depth analysis of the global joint pain injections market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global joint pain injections market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this Pfizer, Inc., Ferring Pharmaceuticals Inc., PACIRA BIOSCIENCES, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Sanofi, Anika Therapeutics, Inc., Bioventus, Dr. Reddy's Laboratories Ltd., Zimmer Biomet, Ferring B.V., and SEIKAGAKU CORPORATION
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global joint pain injections market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global joint pain injections market

Detailed Segmentation-

• By Injection Type:
  • Corticosteroid Injection
  • Hyaluronic Acid Injection
  • Platelet Rich Plasma Injection
  • Others
• By Joint Type:
  • Knee and Ankle
  • Hip Joint
  • Hand and Wrist
  • Other
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Pfizer, Inc.
  • Ferring Pharmaceuticals Inc.
  • PACIRA BIOSCIENCES
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Sanofi
  • Anika Therapeutics, Inc.
  • Bioventus
  • Reddy's Laboratories Ltd.
  • Zimmer Biomet
  • Ferring B.V.
  • SEIKAGAKU CORPORATION

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Injections Type
  • Market Snapshot, By Joint Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Joint Pain Injections Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Joint Pain Injections Market, By Injections Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Corticosteroid Injections
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hyaluronic Acid Injections
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Platelet Rich Plasma Injections
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Joint Pain Injections Market, By Joint Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Knee and Ankle
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hip Joint
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hand and Wrist
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cell Immortalization Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Joint Pain Injections Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Joint Pain Injections Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Pfizer, Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ferring Pharmaceuticals Inc.
  • PACIRA BIOSCIENCES
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Sanofi
  • Anika Therapeutics, Inc.
  • Bioventus
  • Dr. Reddy's Laboratories Ltd.
  • Zimmer Biomet
  • Ferring B.V.
  • SEIKAGAKU CORPORATION

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact